Copyright
©The Author(s) 2022.
World J Gastroenterol. Feb 7, 2022; 28(5): 502-516
Published online Feb 7, 2022. doi: 10.3748/wjg.v28.i5.502
Published online Feb 7, 2022. doi: 10.3748/wjg.v28.i5.502
Table 2 SCENIC international consensus
Term | Definition |
Visible dysplasia | Dysplasia identified on targeted biopsies from a lesion visualized in colonoscopy |
Polypoid | Lesion protruding from the mucosa into the lumen ≥ 2.5 mm |
Pedunculated | Lesion attached to the mucosa by a stalk |
Sessile | Lesion not attached to the mucosa by a stalk: entire base is contiguous with the mucosa |
Nonpolypoid | Lesion with little (< 2.5 mm) or no protrusion above the mucosa |
Superficially elevated | Lesion with protrusion but < 2.5 mm above the lumen (less than the height of the closed cup of a biopsy forceps) |
Flat | Lesion without protrusion above the mucosa |
Depressed | Lesion with at least a portion depressed below the level of the mucosa |
General descriptors | |
Ulcerated | Ulceration (fibrinous base with depth) within the lesion |
Border | |
Distinct border | Border of the lesion is discrete and can be distinguished from surrounding mucosa |
Indistinct border | Border of the lesion is not discrete and cannot be distinguished from surrounding mucosa |
Invisible dysplasia | Dysplasia identified on random (non-targeted) biopsies of colon mucosa without a visible lesion |
- Citation: Huguet JM, Ferrer-Barceló L, Suárez P, Sanchez E, Prieto JD, Garcia V, Sempere J. Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021. World J Gastroenterol 2022; 28(5): 502-516
- URL: https://www.wjgnet.com/1007-9327/full/v28/i5/502.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i5.502